Zydus Wellness Ltd

The investor presentation for Zydus Wellness Limited's Q2 FY2026-27 and H1 FY2026-27 highlights strong revenue growth, with net sales increasing by 74.6% year-on-year in Q2 and 70.1% in H1. Domestic sales grew by 29.2% in Q2, while international sales, including the Comfort Click business, rose by 12.4%. The gross margin expanded to 61.1% in Q2 and 63.5% in H1, driven by higher-margin products and cost management. EBITDA improved significantly, reaching INR 855 million in Q2 and INR 3,272 million in H1, with EBITDA margins rising to 7.6% and 12.8%, respectively. PAT improved to INR 51 million in Q2 and INR 1,240 million in H1. The company emphasized robust growth in key categories like sugar substitutes, protein products, and skincare, supported by digital initiatives, brand campaigns, and strategic acquisitions. The board includes experienced leaders in pharmaceuticals, technology, and finance, with notable recognitions and awards for marketing and digital innovation. The presentation also outlines future strategies aligned with global health trends, including expanding into plant-based nutrition and enhancing international market presence.

The document emphasizes strong revenue growth, margin expansion, and strategic initiatives, reflecting a positive outlook on the company's performance and future direction.